Advertisement
Screener

XENETIC BIOSCIENCES, INC. (XBIO) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

XENETIC BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities

XENETIC BIOSCIENCES, INC. (XBIO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$73.05 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06

  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$63.26K, a 126.86% decline year-over-year.
  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$9.79K.
  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$143.75K.
  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $208.34K.
  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $73.76K, a 12.89% decline from fiscal 2024.
  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $84.68K.
  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$263.57K.
  • XENETIC BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$347.95K, a 176.12% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 7 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 10 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month
2026-06-30-$63.26K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$73.05K
10-Q · filed 2026-08-06
-$216.80K
derived: sum of 3 quarters · filed 2026-08-06
-$8.45K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$9.79K
10-Q · filed 2026-05-12
-$153.54K
derived: sum of 2 quarters · filed 2026-05-12
$54.81K
derived: sum of 3 quarters · filed 2026-05-12
$290.31K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$143.75K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$64.59K
derived: sum of 2 quarters · filed 2026-03-12
$300.10K
derived: sum of 3 quarters · filed 2026-08-06
$73.76K
10-K · filed 2026-03-12
2025-09-30$208.34K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$443.85K
derived: sum of 2 quarters · filed 2026-08-06
$217.51K
10-Q · filed 2025-11-12
$102.37K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$235.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$9.17K
10-Q · filed 2026-08-06
-$105.98K
derived: sum of 3 quarters · filed 2026-08-06
-$684.17K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$226.34K
10-Q · filed 2026-05-12
-$341.48K
derived: sum of 2 quarters · filed 2026-05-12
-$919.67K
derived: sum of 3 quarters · filed 2026-05-12
-$48.57K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31-$115.14K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$693.34K
derived: sum of 2 quarters · filed 2026-03-12
$177.77K
derived: sum of 3 quarters · filed 2026-03-12
$84.68K
10-K · filed 2026-03-12
2024-09-30-$578.20K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$292.91K
derived: sum of 2 quarters · filed 2025-11-12
$199.82K
10-Q · filed 2025-11-12
-$59.09K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$871.11K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$778.02K
10-Q · filed 2025-08-12
$519.11K
derived: sum of 3 quarters · filed 2025-08-12
$716.29K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$93.09K
10-Q · filed 2025-05-13
-$352.00K
derived: sum of 2 quarters · filed 2025-05-13
-$154.82K
derived: sum of 3 quarters · filed 2025-05-13
-$139.87K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$258.91K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
-$61.73K
derived: sum of 2 quarters · filed 2025-03-18
-$46.78K
derived: sum of 3 quarters · filed 2025-03-18
-$263.57K
10-K · filed 2025-03-18
2023-09-30$197.18K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$212.13K
derived: sum of 2 quarters · filed 2024-11-12
-$4.66K
10-Q · filed 2024-11-12
$17.64K
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$14.95K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$201.84K
10-Q · filed 2024-08-13
-$179.54K
derived: sum of 3 quarters · filed 2024-08-13
-$407.87K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$216.79K
10-Q · filed 2024-05-09
-$194.49K
derived: sum of 2 quarters · filed 2024-05-09
-$422.82K
derived: sum of 3 quarters · filed 2024-05-09
-$206.90K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$22.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
-$206.03K
derived: sum of 2 quarters · filed 2024-03-21
$9.89K
derived: sum of 3 quarters · filed 2024-03-21
-$347.95K
10-K · filed 2024-03-21
2022-09-30-$228.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$12.41K
derived: sum of 2 quarters · filed 2023-11-09
-$370.25K
10-Q · filed 2023-11-09
-$70.64K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$215.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$141.92K
10-Q · filed 2023-08-10
$157.69K
derived: sum of 3 quarters · filed 2023-08-10
$313.01K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$357.83K
10-Q · filed 2023-05-11
-$58.23K
derived: sum of 2 quarters · filed 2023-05-11
$97.10K
derived: sum of 3 quarters · filed 2023-05-11
$247.51K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$299.61K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$454.93K
derived: sum of 2 quarters · filed 2023-03-22
$605.34K
derived: sum of 3 quarters · filed 2023-03-22
$457.13K
10-K · filed 2023-03-22
2021-09-30$155.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$305.74K
derived: sum of 2 quarters · filed 2022-11-09
$157.52K
10-Q · filed 2022-11-09
$262.46K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$150.41K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$2.20K
10-Q · filed 2022-08-11
$107.13K
derived: sum of 3 quarters · filed 2022-08-11
$108.28K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$148.21K
10-Q · filed 2022-05-12
-$43.28K
derived: sum of 2 quarters · filed 2022-05-12
-$42.13K
derived: sum of 3 quarters · filed 2022-05-12
-$618.47K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$104.93K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22
$106.08K
derived: sum of 2 quarters · filed 2022-03-22
-$470.25K
derived: sum of 3 quarters · filed 2022-03-22
-$378.11K
10-K · filed 2022-03-22
2020-09-30$1.15K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$575.19K
derived: sum of 2 quarters · filed 2021-11-12
-$483.05K
10-Q · filed 2021-11-12
-$765.18K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$576.33K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$484.19K
10-Q · filed 2021-08-12
-$766.32K
derived: sum of 3 quarters · filed 2021-08-12
-$1.39M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$92.14K
10-Q · filed 2021-05-11
-$189.99K
derived: sum of 2 quarters · filed 2021-05-11
-$816.58K
derived: sum of 3 quarters · filed 2021-05-11
-$511.85K
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31-$282.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
-$908.73K
derived: sum of 2 quarters · filed 2021-03-16
-$603.99K
derived: sum of 3 quarters · filed 2021-03-16
-$227.96K
10-K · filed 2021-03-16
2019-09-30-$626.60K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$321.86K
derived: sum of 2 quarters · filed 2020-11-12
$54.17K
10-Q · filed 2020-11-12
$334.29K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$304.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$680.77K
10-Q · filed 2020-08-12
$960.88K
derived: sum of 3 quarters · filed 2020-08-12
$726.46K
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$376.03K
10-Q · filed 2020-05-14
$656.14K
derived: sum of 2 quarters · filed 2020-05-14
$421.72K
derived: sum of 3 quarters · filed 2020-05-14
$236.46K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$280.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$45.70K
derived: sum of 2 quarters · filed 2020-03-26
-$139.56K
derived: sum of 3 quarters · filed 2020-03-26
-$343.88K
10-K · filed 2020-03-26
2018-09-30-$234.42K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$419.68K
derived: sum of 2 quarters · filed 2019-11-14
-$623.99K
10-Q · filed 2019-11-14
-$846.55K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$185.26K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$389.57K
10-Q · filed 2019-08-14
-$612.13K
derived: sum of 3 quarters · filed 2019-08-14
-$457.05K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$204.31K
10-Q · filed 2019-05-13
-$426.87K
derived: sum of 2 quarters · filed 2019-05-13
-$271.79K
derived: sum of 3 quarters · filed 2019-05-13
-$269.77K
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31-$222.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$67.47K
derived: sum of 2 quarters · filed 2019-03-29
-$65.46K
derived: sum of 3 quarters · filed 2019-03-29
-$8.18K
10-K · filed 2019-03-29
2017-09-30$155.09K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$157.10K
derived: sum of 2 quarters · filed 2018-11-09
$214.38K
10-Q · filed 2018-11-09
-$1.80M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$2.01K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
$59.29K
10-Q · filed 2018-08-10
-$1.96M
derived: sum of 3 quarters · filed 2018-08-10
-$1.38M
derived: sum of 4 quarters · filed 2018-08-10
2017-03-31$57.28K
10-Q · filed 2018-05-15
-$1.96M
derived: sum of 2 quarters · filed 2018-05-15
-$1.38M
derived: sum of 3 quarters · filed 2018-05-15
-$813.41K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$2.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
-$1.44M
derived: sum of 2 quarters · filed 2018-03-30
-$870.69K
derived: sum of 3 quarters · filed 2018-03-30
-$1.02M
10-K · filed 2018-03-30
2016-09-30$575.68K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$1.15M
derived: sum of 2 quarters · filed 2017-11-14
$997.50K
10-Q · filed 2017-11-14
$1.36M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$569.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$421.82K
10-Q · filed 2017-08-14
$780.05K
derived: sum of 3 quarters · filed 2017-08-14
$679.13K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31-$147.72K
10-Q · filed 2017-05-15
$210.51K
derived: sum of 2 quarters · filed 2017-05-15
$109.59K
derived: sum of 3 quarters · filed 2017-05-15
$614.41K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$358.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
$257.31K
derived: sum of 2 quarters · filed 2017-03-31
$762.13K
derived: sum of 3 quarters · filed 2017-03-31
$943.91K
10-K · filed 2017-03-31
2015-09-30-$100.92K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$403.90K
derived: sum of 2 quarters · filed 2016-11-14
$585.68K
10-Q · filed 2016-11-14
$1.29M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$504.81K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$686.60K
10-Q · filed 2016-08-15
$1.39M
derived: sum of 3 quarters · filed 2016-08-15
$1.69M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$181.78K
10-Q · filed 2016-05-16
$888.80K
derived: sum of 2 quarters · filed 2016-05-16
$1.18M
derived: sum of 3 quarters · filed 2016-05-16
$543.59K
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$707.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$999.43K
derived: sum of 2 quarters · filed 2016-03-30
$361.81K
derived: sum of 3 quarters · filed 2016-03-30
-$479.01K
10-K · filed 2016-03-30
2014-09-30$292.41K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
-$345.21K
derived: sum of 2 quarters · filed 2015-11-16
-$1.19M
10-Q · filed 2015-11-16
$236.99K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30-$637.62K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19
-$1.48M
10-Q · filed 2015-08-19
-$55.42K
derived: sum of 3 quarters · filed 2015-08-19
$332.20K
derived: sum of 4 quarters · filed 2015-08-19
2014-03-31-$840.83K
10-Q · filed 2015-05-20
$582.20K
derived: sum of 2 quarters · filed 2015-07-20
$969.82K
derived: sum of 3 quarters · filed 2015-07-20
$1.08M
derived: sum of 4 quarters · filed 2015-07-20
2013-12-31$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20
$1.81M
derived: sum of 2 quarters · filed 2015-07-20
$1.92M
derived: sum of 3 quarters · filed 2015-07-20
$2.07M
10-K · filed 2015-07-20
2013-09-30$387.62K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$497.71K
derived: sum of 2 quarters · filed 2014-11-14
$643.15K
10-Q · filed 2014-11-14
2013-06-30$110.09K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$255.53K
10-Q · filed 2014-08-14
2013-03-31$145.43K
10-Q · filed 2014-05-20
2012-12-31-$1.44M
10-K · filed 2015-07-20
2012-05-31$53.44K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-16
$122.87K
10-Q · filed 2012-07-16
$130.24K
10-Q · filed 2012-07-16
2012-02-29$69.42K
10-Q · filed 2012-04-24
$76.80K
10-Q · filed 2012-04-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Pulmatrix, Inc. (PULM)United States$0.006B
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63